Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Deloitte
Julphar
Covington
Johnson and Johnson
Argus Health
Queensland Health
Healthtrust
Citi

Generated: May 27, 2018

DrugPatentWatch Database Preview

TECHNETIUM TC 99M DIPHOSPHONATE-TIN KIT Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Technetium Tc 99m Diphosphonate-tin Kit, and when can generic versions of Technetium Tc 99m Diphosphonate-tin Kit launch?

Technetium Tc 99m Diphosphonate-tin Kit is a drug marketed by Ge Healthcare and is included in one NDA.

The generic ingredient in TECHNETIUM TC 99M DIPHOSPHONATE-TIN KIT is technetium tc-99m etidronate kit. There are four drug master file entries for this compound. Additional details are available on the technetium tc-99m etidronate kit profile page.
Summary for TECHNETIUM TC 99M DIPHOSPHONATE-TIN KIT
US Patents:0
Applicants:1
NDAs:1
Clinical Trials: 89
DailyMed Link:TECHNETIUM TC 99M DIPHOSPHONATE-TIN KIT at DailyMed
Drug patent expirations by year for TECHNETIUM TC 99M DIPHOSPHONATE-TIN KIT

US Patents and Regulatory Information for TECHNETIUM TC 99M DIPHOSPHONATE-TIN KIT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Healthcare TECHNETIUM TC 99M DIPHOSPHONATE-TIN KIT technetium tc-99m etidronate kit INJECTABLE;INJECTION 017562-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Harvard Business School
Federal Trade Commission
Express Scripts
Cerilliant
Boehringer Ingelheim
Johnson and Johnson
US Army
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.